We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+9.36%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$2.48B
AUM Growth
+$152M
Cap. Flow
+$58.2M
Cap. Flow %
2.35%
Top 10 Hldgs %
26.38%
Holding
291
New
33
Increased
134
Reduced
93
Closed
18

Sector Composition

Rank Sector Weight
1 Healthcare 24.68%
2 Technology 21.94%
3 Industrials 17.48%
4 Consumer Discretionary 13.63%
5 Communication Services 6.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRGS icon
76
Progress Software
PRGS
$1.78B
$6.91M 0.28%
188,252
-80,730
-30% -$2.94M
FIVE icon
77
Five Below
FIVE
$13B
$6.85M 0.28%
53,964
-25,523
-32% -$2.9M
CSII
78
DELISTED
Cardiovascular Systems, Inc.
CSII
$6.83M 0.28%
173,510
-24,416
-12% -$789K
PZZA icon
79
Papa John's
PZZA
$785M
$6.73M 0.27%
81,844
-40,954
-33% -$3.76M
FC icon
80
Franklin Covey
FC
$242M
$6.68M 0.27%
376,497
+54,702
+17% +$1.05M
OMCL icon
81
Omnicell
OMCL
$1.7B
$6.55M 0.26%
87,705
-51,195
-37% -$3.55M
TTEK icon
82
Tetra Tech
TTEK
$8.97B
$6.18M 0.25%
323,500
-190,425
-37% -$3.38M
BMRN icon
83
BioMarin Pharmaceuticals
BMRN
$13.3B
$6.15M 0.25%
80,873
+9,991
+14% +$1.01M
ACLS icon
84
Axcelis
ACLS
$4.1B
$6.06M 0.24%
275,435
-25,524
-8% -$651K
VICR icon
85
Vicor
VICR
$9.63B
$5.9M 0.24%
75,938
-55,262
-42% -$4.4M
PBYI icon
86
Puma Biotechnology
PBYI
$442M
$5.86M 0.24%
580,995
+125,428
+28% +$1.28M
LSCC icon
87
Lattice Semiconductor
LSCC
$18.2B
$5.86M 0.24%
202,294
-224,037
-53% -$6.59M
CSW
88
CSW Industrials
CSW
$5.67B
$5.85M 0.24%
75,680
+24,226
+47% +$1.76M
ROCK icon
89
Gibraltar Industries
ROCK
$1.45B
$5.8M 0.23%
+89,010
New +$5.25M
MTZ icon
90
MasTec
MTZ
$21.5B
$5.62M 0.23%
133,121
-57,857
-30% -$2.49M
FN icon
91
Fabrinet
FN
$18.9B
$5.53M 0.22%
87,755
-20,784
-19% -$1.4M
EHC icon
92
Encompass Health
EHC
$12.5B
$5.47M 0.22%
105,751
-61,441
-37% -$3.15M
MATX icon
93
Matsons
MATX
$6.24B
$5.39M 0.22%
134,452
-73,127
-35% -$2.76M
CHRS icon
94
Coherus Oncology
CHRS
$192M
$5.21M 0.21%
284,361
-166,571
-37% -$3.1M
CVET
95
DELISTED
Covetrus, Inc. Common Stock
CVET
$5.06M 0.2%
207,362
-121,382
-37% -$2.62M
GLUU
96
DELISTED
Glu Mobile Inc.
GLUU
$5M 0.2%
651,565
-228,287
-26% -$1.92M
ENSG icon
97
The Ensign Group
ENSG
$10.7B
$4.97M 0.2%
87,032
-43,580
-33% -$2.25M
CUB
98
DELISTED
Cubic Corporation
CUB
$4.96M 0.2%
85,358
-64,996
-43% -$3.06M
ICFI icon
99
ICF International
ICFI
$1.66B
$4.91M 0.2%
79,839
-47,247
-37% -$3.14M
CALY
100
Callaway Golf Company
CALY
$3.04B
$4.91M 0.2%
256,550
-151,111
-37% -$2.84M

Similar funds

Rice Hall James & Associates's Q3 2020 Portfolio in Review

As of Q3 2020, Rice Hall James & Associates held 291 positions worth $2.48B, up 6.5% from $2.33B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Rice Hall James & Associates's Q3 2020 filing shows 33 new, 134 increased, 93 reduced and 18 closed positions. Its largest new stake was Fate Therapeutics: 326,844 shares worth $13.1M. The largest sale was Trade Desk, an estimated $28.2M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 25% a quarter earlier, followed by Technology and Industrials.

  • Rice Hall James & Associates's largest Q3 2020 buy was Fate Therapeutics: 326,844 shares worth $13.1M.
  • Rice Hall James & Associates added most to Ziff Davis in Q3 2020, an estimated $32.7M increase.
  • Rice Hall James & Associates's biggest Q3 2020 reduction was Trade Desk, cutting an estimated $28.2M.
  • Rice Hall James & Associates fully exited Aerojet Rocketdyne Holdings in Q3 2020, selling an estimated $8.48M.
  • Rice Hall James & Associates's ten largest holdings make up 26% of its $2.48B portfolio in Q3 2020.
  • Rice Hall James & Associates opened 33 new positions and closed 18 in Q3 2020.
  • Rice Hall James & Associates's portfolio value rose 6.5% quarter-over-quarter to $2.48B.

Based on Rice Hall James & Associates's 13F filing for Q3 2020, filed 16 Nov 2020.